New Beckman CEO Presses On Business Development | GenomeWeb

Almost a month to the day after becoming the new CEO of Beckman Coulter, Scott Garrett last week targeted top-line revenue growth as the lynchpin for meeting the company's ambitious earnings targets.

"We have achieved double-digit earnings growth in nearly every year since the Coulter acquisition in 1997," Garrett said in a webcast of the company's annual business review meeting held in New York City last week. "We expect to continue that growth but we need to focus on double-digit sales growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.